TerrAscend Future Growth
Future criteria checks 4/6
TerrAscend is forecast to grow earnings and revenue by 117.6% and 11.1% per annum respectively. EPS is expected to grow by 117.6% per annum. Return on equity is forecast to be 11.4% in 3 years.
Key information
117.6%
Earnings growth rate
117.6%
EPS growth rate
Pharmaceuticals earnings growth | 20.7% |
Revenue growth rate | 11.1% |
Future return on equity | 11.4% |
Analyst coverage | Good |
Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 440 | 54 | 6 | 11 | 2 |
12/31/2025 | 386 | 16 | 25 | 3 | 5 |
12/31/2024 | 347 | -14 | 32 | 36 | 9 |
12/31/2023 | 317 | -91 | 17 | 27 | N/A |
9/30/2023 | 300 | -50 | 3 | 25 | N/A |
6/30/2023 | 277 | -342 | -6 | 18 | N/A |
3/31/2023 | 269 | -311 | -35 | 1 | N/A |
12/31/2022 | 248 | -304 | -69 | -26 | N/A |
9/30/2022 | 212 | -298 | -77 | -37 | N/A |
6/30/2022 | 195 | 59 | -100 | -57 | N/A |
3/31/2022 | 189 | 13 | -94 | -57 | N/A |
12/31/2021 | 194 | 13 | -72 | -32 | N/A |
9/30/2021 | 211 | -96 | -114 | -70 | N/A |
6/30/2021 | 200 | -165 | -102 | -53 | N/A |
3/31/2021 | 175 | -144 | -78 | -30 | N/A |
12/31/2020 | 132 | -125 | -82 | -37 | N/A |
9/30/2020 | 118 | -159 | -47 | -1 | N/A |
6/30/2020 | 99 | -156 | -41 | -2 | N/A |
3/31/2020 | 75 | -155 | -58 | -25 | N/A |
12/31/2019 | 64 | -161 | -74 | -40 | N/A |
9/30/2019 | 48 | -44 | -54 | -32 | N/A |
6/30/2019 | 30 | -33 | -52 | -33 | N/A |
3/31/2019 | 16 | -23 | -43 | -26 | N/A |
12/31/2018 | 5 | -16 | -30 | -20 | N/A |
9/30/2018 | 1 | -9 | -29 | -21 | N/A |
6/30/2018 | 0 | -8 | -23 | -17 | N/A |
3/31/2018 | N/A | -7 | -12 | -6 | N/A |
12/31/2017 | N/A | -5 | -15 | -3 | N/A |
9/30/2017 | N/A | -5 | N/A | -3 | N/A |
6/30/2017 | N/A | -4 | N/A | 0 | N/A |
3/31/2017 | N/A | -1 | N/A | -1 | N/A |
12/31/2016 | N/A | -1 | N/A | 0 | N/A |
12/31/2015 | N/A | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TED is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: TED is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TED is expected to become profitable in the next 3 years.
Revenue vs Market: TED's revenue (11.1% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: TED's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TED's Return on Equity is forecast to be low in 3 years time (11.4%).